James joined Charnwood Molecular in December 2016 as Head of Medicinal Chemistry and was promoted to Vice President of Chemistry in 2022.
James graduated from the University of Sheffield with a degree in Chemistry, and holds a PhD from the University of Liverpool. He brings extensive experience from across multiple therapeutic areas in drug discovery, having previously held positions at SAFC Pharma, Pfizer Pharmaceuticals, KemFine Oy and CRUK.
Prior to joining Charnwood, James was Senior Medicinal Chemist at the Cancer Research UK Manchester Institute, where he worked on various target classes, including kinases and epigenetic targets. James has led numerous projects from hit identification right through to lead optimization and beyond, and has an in-depth knowledge of modern drug discovery, as exemplified by his impressive publication record.